Correction to: Preconditioning with VEGF Enhances Angiogenic and Neuroprotective Effects of Bone Marrow Mononuclear Cell Transplantation in a Rat Model of Chronic Cerebral Hypoperfusion (Molecular Neurobiology, (2016), 53, 9, (6057-6068), 10.1007/s12035-015-9512-8);Preconditioning with VEGF Enhances Angiogenic and Neuroprotective Effects of Bone Marrow Mononuclear Cell Transplantation in a Rat Model of Chronic Cerebral Hypoperfusion

Molecular Neurobiology

Volumn 53, Issue 9, 2016, Pages 6057-6068

  Wang, Jianping ^a   Fu, Xiaojie ^a   Yu, Lie ^a   Li, Nan ^a   Wang, Menghan ^a   Liu, Xi ^a   Zhang, Di ^a   Han, Wei ^a   Zhou, Chenguang ^a   Wang, Jian ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Bone marrow mononuclear cells; Cell transplantation; Chronic cerebral hypoperfusion; VEGF

Indexed keywords

CYTOKINE; KI 67 ANTIGEN; LECTIN; RECOMBINANT VASCULOTROPIN; CLAUDIN 5; NEUROPROTECTIVE AGENT; PROTEIN ZO1; VASCULOTROPIN A;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BONE MARROW TRANSPLANTATION; BRAIN EDEMA; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CELL MIGRATION; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; COGNITION; COMMON CAROTID ARTERY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNCTIONAL ASSESSMENT; IMMUNOFLUORESCENCE TEST; ISCHEMIC PRECONDITIONING; LEARNING DISORDER; MALE; MEMBRANE PERMEABILITY; MEMORY DISORDER; MONONUCLEAR CELL; MORRIS WATER MAZE TEST; NERVE CELL DEGENERATION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PROTEIN FUNCTION; RAT; STAINING; THERAPY EFFECT; ANIMAL; CELL MOTION; DISEASE MODEL; DRUG EFFECTS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BONE MARROW TRANSPLANTATION; BRAIN ISCHEMIA; CELL MOVEMENT; CHRONIC DISEASE; CLAUDIN-5; COGNITION; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAVENTRICULAR; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPROTECTIVE AGENTS; PERMEABILITY; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84946119891     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-020-01898-2     Document Type: Erratum

References (45)

1. Liu J, Wang LN, Tan JP (2013) Dementia in China: current status. Neurology 81(12):1077–1078. doi:10.1212/WNL.0b013e3182a4a3cb
2. Jia J, Wang F, Wei C, Zhou A, Jia X, Li F, Tang M, Chu L et al (2014) The prevalence of dementia in urban and rural areas of China. Alzheimer Dement: J Alzheimer Assoc 10(1):1–9
3. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A et al (2008) Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 7(9):812–826
4. Brown WR, Thore CR (2011) Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 37(1):56–74. doi:10.1111/j.1365-2990.2010.01139.x
5. Baskys A, Cheng JX (2012) Pharmacological prevention and treatment of vascular dementia: approaches and perspectives. Exp Gerontol 47(11):887–891. doi:10.1016/j.exger.2012.07.002
6. Giraldi-Guimaraes A, de Freitas HT, Coelho Bde P, Macedo-Ramos H, Mendez-Otero R, Cavalcante LA, Baetas-da-Cruz W (2012) Bone marrow mononuclear cells and mannose receptor expression in focal cortical ischemia. Brain Res 1452:173–184. doi:10.1016/j.brainres.2012.03.002
7. Wang J, Yu L, Jiang C, Chen M, Ou C, Wang J (2013) Bone marrow mononuclear cells exert long-term neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis. Brain Behav Immun 34:56–66. doi:10.1016/j.bbi.2013.07.010
8. Wang J, Liu X, Lu H, Jiang C, Cui X, Yu L, Fu X, Li Q, Wang J (2015) CXCR4(+)CD45(−) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice. Brain Behav Immun 45:98–108. doi:10.1016/j.bbi.2014.12.015
9. Brenneman M, Sharma S, Harting M, Strong R, Cox CS Jr, Aronowski J, Grotta JC, Savitz SI (2010) Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab 30(1):140–149. doi:10.1038/jcbfm.2009.198
10. Sharma S, Yang B, Strong R, Xi X, Brenneman M, Grotta JC, Aronowski J, Savitz SI (2010) Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke. J Neurosci Res 88(13):2869–2876. doi:10.1002/jnr.22452
11. Savitz SI, Misra V, Kasam M, Juneja H, Cox CS Jr, Alderman S, Aisiku I, Kar S et al (2011) Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol 70(1):59–69. doi:10.1002/ana.22458
12. Yang B, Migliati E, Parsha K, Schaar K, Xi X, Aronowski J, Savitz SI (2013) Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. Stroke 44(12):3463–3472. doi:10.1161/STROKEAHA.111.000821
13. Friedrich MA, Martins MP, Araujo MD, Klamt C, Vedolin L, Garicochea B, Raupp EF, Sartori El Ammar J et al (2012) Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke. Cell Transplant 21(1):S13–S21. doi:10.3727/096368911X612512
14. Rosado-de-Castro PH, Schmidt Fda R, Battistella V, de Souza SA L, Gutfilen B, Goldenberg RC, Kasai-Brunswick TH, Vairo L et al (2013) Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. Regen Med 8(2):145–155. doi:10.2217/rme.13.2
15. Xu Y, Hu X, Wang L, Jiang Z, Liu X, Yu H, Zhang Z, Chen H et al (2013) Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair. PLoS One 8(12), e82997
16. Matoba S, Matsubara H (2009) Therapeutic angiogenesis for peripheral artery diseases by autologous bone marrow cell transplantation. Curr Pharm Des 15(24):2769–2777
17. Ruiz-Salmeron R, de la Cuesta-Diaz A, Constantino-Bermejo M, Perez-Camacho I, Marcos-Sanchez F, Hmadcha A, Soria B (2011) Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia. Cell Transplant 20(10):1629–1639
18. Jiwa NS, Garrard P, Hainsworth AH (2010) Experimental models of vascular dementia and vascular cognitive impairment: a systematic review. J Neurochem 115(4):814–828
19. Wang J, Fu X, Jiang C, Yu L, Wang M, Han W, Liu L, Wang J (2014) Bone marrow mononuclear cell transplantation promotes therapeutic angiogenesis via upregulation of the VEGF-VEGFR2 signaling pathway in a rat model of vascular dementia. Behav Brain Res 265:171–180
20. Miki Y, Nonoguchi N, Ikeda N, Coffin RS, Kuroiwa T, S-i M (2007) Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia. Neurosurgery 61(3):586–594, discussion 594–585
21. Chang YS, Ahn SY, Jeon HB, Sung DK, Kim ES, Sung SI, Yoo HS, Choi SJ et al (2014) Critical role of VEGF secreted by mesenchymal stem cells in hyperoxic lung injury. Am J Respir Cell Mol Biol. doi:10.1165/rcmb.2013-0385OC
22. Horie N, Pereira MP, Niizuma K, Sun G, Keren-Gill H, Encarnacion A, Shamloo M, Hamilton SA et al (2011) Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells 29(2):274–285. doi:10.1002/stem.584
23. Ma Y, Qu Y, Fei Z (2011) Vascular endothelial growth factor in cerebral ischemia. J Neurosci Res 89(7):969–978. doi:10.1002/jnr.22628
24. Zechariah A, ElAli A, Doeppner TR, Jin F, Hasan MR, Helfrich I, Mies G, Hermann DM (2013) Vascular endothelial growth factor promotes pericyte coverage of brain capillaries, improves cerebral blood flow during subsequent focal cerebral ischemia, and preserves the metabolic penumbra. Stroke 44(6):1690–1697. doi:10.1161/STROKEAHA.111.000240
25. Chen J, Zhang C, Jiang H, Li Y, Zhang L, Robin A, Katakowski M, Lu M et al (2005) Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab 25(2):281–290. doi:10.1038/sj.jcbfm.9600034
26. Bleier BS, Kohman RE, Feldman RE, Ramanlal S, Han X (2013) Permeabilization of the blood–brain barrier via mucosal engrafting: implications for drug delivery to the brain. PLoS One 8(4), e61694. doi:10.1371/journal.pone.0061694
27. Choy M, Ganesan V, Thomas DL, Thornton JS, Proctor E, King MD, van der Weerd L, Gadian DG et al (2006) The chronic vascular and haemodynamic response after permanent bilateral common carotid occlusion in newborn and adult rats. J Cereb Blood Flow Metab 26(8):1066–1075. doi:10.1038/sj.jcbfm.9600259
28. Jiang C, Wang J, Yu L, Ou C, Liu X, Zhao X, Wang J (2013) Comparison of the therapeutic effects of bone marrow mononuclear cells and microglia for permanent cerebral ischemia. Behav Brain Res 250:222–229. doi:10.1016/j.bbr.2013.05.011
29. Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, Van Damme P, Rutten B et al (2005) Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 8(1):85–92. doi:10.1038/nn1360
30. Nowacka MM, Obuchowicz E (2012) Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides 46(1):1–10. doi:10.1016/j.npep.2011.05.005
31. Yang B, Strong R, Sharma S, Brenneman M, Mallikarjunarao K, Xi X, Grotta JC, Aronowski J et al (2011) Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J Neurosci Res 89(6):833–839. doi:10.1002/jnr.22614
32. Chang CF, Cho S, Wang J (2014) (−)-Epicatechin protects hemorrhagic brain via synergistic Nrf2 pathways. Ann Clin Transl Neurol 1(4):258–271. doi:10.1002/acn3.54
33. Farkas E, Luiten PG, Bari F (2007) Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev 54(1):162–180. doi:10.1016/j.brainresrev.2007.01.003
34. Feng Y, Rhodes PG, Bhatt AJ (2008) Neuroprotective effects of vascular endothelial growth factor following hypoxic ischemic brain injury in neonatal rats. Pediatr Res 64(4):370–374. doi:10.1203/PDR.0b013e318180ebe6
35. Cechetti F, Worm PV, Pereira LO, Siqueira IR CAN (2010) The modified 2VO ischemia protocol causes cognitive impairment similar to that induced by the standard method, but with a better survival rate. Braz J Med Biol Res 43(12):1178–1183
36. Manaenko A, Chen H, Kammer J, Zhang JH, Tang J (2011) Comparison Evans blue injection routes: intravenous versus intraperitoneal, for measurement of blood–brain barrier in a mice hemorrhage model. J Neurosci Methods 195(2):206–210. doi:10.1016/j.jneumeth.2010.12.013
37. Chang SH, Mirabolfathinejad SG, Katta H, Cumpian AM, Gong L, Caetano MS, Moghaddam SJ, Dong C (2014) T helper 17 cells play a critical pathogenic role in lung cancer. Proc Natl Acad Sci U S A 111(15):5664–5669. doi:10.1073/pnas.1319051111
38. Wang J, Fields J, Zhao C, Langer J, Thimmulappa RK, Kensler TW, Yamamoto M, Biswal S et al (2007) Role of Nrf2 in protection against intracerebral hemorrhage injury in mice. Free Radic Biol Med 43(3):408–414. doi:10.1016/j.freeradbiomed.2007.04.020
39. Donega V, van Velthoven CT, Nijboer CH, Kavelaars A, Heijnen CJ (2013) The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment. J Cereb Blood Flow Metab 33(5):625–634. doi:10.1038/jcbfm.2013.3
40. Darsalia V, Allison SJ, Cusulin C, Monni E, Kuzdas D, Kallur T, Lindvall O, Kokaia Z (2011) Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J Cereb Blood Flow Metab 31(1):235–242. doi:10.1038/jcbfm.2010.81
41. Hecht N, Schneider UC, Czabanka M, Vinci M, Hatzopoulos AK, Vajkoczy P, Woitzik J (2014) Endothelial progenitor cells augment collateralization and hemodynamic rescue in a model of chronic cerebral ischemia. J Cereb Blood Flow Metab 34(8):1297–1305. doi:10.1038/jcbfm.2014.78
42. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA, Cox CS Jr (2009) Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18(5):683–692. doi:10.1089/scd.2008.0253
43. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P et al (2009) Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5(1):54–63. doi:10.1016/j.stem.2009.05.003
44. Wang J, Yu L, Jiang C, Fu X, Liu X, Wang M, Ou C, Cui X et al (2015) Cerebral ischemia increases bone marrow CD4+CD25+FoxP3+ regulatory T cells in mice via signals from sympathetic nervous system. Brain Behav Immun 43:172–183. doi:10.1016/j.bbi.2014.07.022
45. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A et al (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380(6573):435–439. doi:10.1038/380435a0